<DOC>
	<DOCNO>NCT00414193</DOCNO>
	<brief_summary>Nosocomial bloodstream infection important cause morbidity mortality cause AmpC beta-lactamase-producing Enterobacteriaceae . The information collect optimize management patient nosocomial bloodstream infection .</brief_summary>
	<brief_title>Piperacillin/Tazobactam Bacteremia With Organisms Producing Chromosomally-Encoded AmpC Beta-Lactamase</brief_title>
	<detailed_description>The following information collect : age , sex , occupation , hospital location time positive culture ( ER , medical ward , ICU etc ) , prior hospitalization , receipt outpatient dialysis , home care regular medical care ( eg , outpatient chemotherapy ) , presence invasive device , receipt antibiotic , include type whether adequate resistance profile organism , prior positive microbiologic culture , time location positive culture , underlie disease severity illness , presence urinary intravascular device , recent immunomodulative therapy radiation therapy , physical exam finding , laboratory radiographical data , antimicrobial usage within 30 day onset infection , microbiological data resistance pattern , choice antibiotic organism identify , bacteriological outcome , laboratory result , demographic information , medication , clinical outcome , gender , height , weight , ethnicity , past medical history . We collect information retrospectively .</detailed_description>
	<mesh_term>Bacteremia</mesh_term>
	<mesh_term>Tazobactam</mesh_term>
	<mesh_term>Piperacillin</mesh_term>
	<mesh_term>Piperacillin , tazobactam drug combination</mesh_term>
	<mesh_term>Penicillanic Acid</mesh_term>
	<criteria>Clinical information collect chart review `` case '' `` control '' patient . A `` case '' patient define follow : One blood culture positive E. cloaca , E. aerogenes , C. freundii , S. marcescens M. morganii . The patient receive piperacillin/tazobactam initial empiric therapy . The organism susceptible piperacillin/tazobactam . A `` control '' patient define follow : One blood culture positive E. cloaca , E. aerogenes , C. freundii , S. marcescens M. morganii . The patient receive carbapenem fluoroquinolone antimicrobial initial empiric therapy . The organism susceptible empiric regimen .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>AmpC beta-lactamase</keyword>
	<keyword>Bacteremia</keyword>
	<keyword>Piperacillin</keyword>
	<keyword>Tazobactam</keyword>
</DOC>